| ￥3500 | |
| Z04144-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus/Rhesus macaque | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its ability to cleave the fluorogenic peptide substrate, GlyPro7amido4methylcoumarin (GPAMC). Test result meets the standard. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 86.11 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 95-115 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Supplied as 0.22μm filtered solution in PBS, 20% Glycerol (pH 7.4). | ||||
| Concentration | Verified by one or more methods from A280/Bioactivity/BCA/Bradford. | ||||
| Storage & Stability | This product remains stable for 6 months at -80°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | CD26/dipeptidyl peptidase (DPP)IV is a membrane-bound protein found in many cell types of the body, and a soluble form is present in body fluids. There is longstanding evidence that various primary tumors and also metastases express DPPIV/CD26 to a variable extent. |
| Synonyms | ADCP2; CD26; DPPIV; DPP4; ADABP; TP103; EC 3.4.14.5 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
